Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001728117-25-000036
Filing Date
2025-05-15
Accepted
2025-05-15 16:01:31
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q goss-20250331.htm   iXBRL 10-Q 818566
2 EX-31.1 goss-20250331x10qxexx311.htm EX-31.1 10019
3 EX-31.2 goss-20250331x10qxexx312.htm EX-31.2 10046
4 EX-32.1 goss-20250331x10qxexx321.htm EX-32.1 5005
5 EX-32.2 goss-20250331x10qxexx322.htm EX-32.2 5044
  Complete submission text file 0001728117-25-000036.txt   5757569

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250331.xsd EX-101.SCH 50094
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT goss-20250331_cal.xml EX-101.CAL 64083
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20250331_def.xml EX-101.DEF 221321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250331_lab.xml EX-101.LAB 633043
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250331_pre.xml EX-101.PRE 419244
73 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250331_htm.xml XML 655910
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38796 | Film No.: 25952393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)